Παραπομπή APA

Dietrich, P., Gaza, A., Wormser, L., Fritz, V., Hellerbrand, C., & Bosserhoff, A. K. (2019). Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma(). Neoplasia.

Παραπομπή Chicago Style

Dietrich, Peter, Anne Gaza, Laura Wormser, Valerie Fritz, Claus Hellerbrand, και Anja Katrin Bosserhoff. "Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma()." Neoplasia 2019.

Παραπομπή MLA

Dietrich, Peter, et al. "Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma()." Neoplasia 2019.

Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.